Market Cap

Ultragenyx Pharmaceutical Inc. Market Capitalization:

$3.64 Billion

USD as of July 1, 2024

business Ultragenyx Pharmaceutical Inc. Company Profile

Ultragenyx Pharmaceutical Inc. Main Stock Listing

NASDAQ: RARE

Market Capitalization History of Ultragenyx Pharmaceutical Inc.

Market capitalizations are calculated from the opening stock price at the beginning of each month.

Top Competitors by Market Capitalization

Industry: Biotechnology
Company Market Cap (USD)
Novo Nordisk $622.07 B
Vertex Pharmaceuticals Incorporated $121.36 B
Regeneron Pharmaceuticals, Inc. $115.11 B
CSL Limited $95.75 B
Marinomed Biotech AG $75.67 B
Sector: Healthcare
Company Market Cap (USD)
Lilly $808.65 B
Novo Nordisk $622.07 B
UnitedHealth Group $450.89 B
Johnson & Johnson $350.63 B
Merck $318.75 B

Yearly evolution of Ultragenyx Pharmaceutical Inc. market cap

Date Market Cap YoY Change
Jan. 1, 2024 $3.94 B 18.96%
Jan. 1, 2023 $3.31 B -33.28%
Jan. 1, 2022 $4.96 B -49.54%
Jan. 1, 2021 $9.84 B 163.73%
Jan. 1, 2020 $3.73 B 6.55%
Jan. 1, 2019 $3.50 B -7.55%
Jan. 1, 2018 $3.79 B -28.88%
Jan. 1, 2017 $5.33 B 33.59%
Jan. 1, 2016 $3.99 B -3.36%
Jan. 1, 2015 $4.12 B 37.51%
Jan. 1, 2014 $3.00 B

Market capitalization is calculated from the opening stock price at the beginning of each year.

Top 1-year algo backtest: +265.99%

$10,000 in October 2023 would now be $36,599 by following this algorithm daily at market close.

Use AI to boost your investing & swing trading, now!

Try Disfold DeepFinance FREE

Ultragenyx Pharmaceutical Inc. Categories

United States languages Healthcare languages Biotechnology
United States Healthcare United States Biotechnology

Stocks & Indices

Ultragenyx Pharmaceutical Inc. has the following listings and related stock indices.


Stock: NASDAQ: RARE

Stock: FSX: UP0

What is a company's market capitalization?

The market capitalization of a company, more simply referred to as "market cap", is the total market value of a publicly traded company's outstanding shares. It is often considered as a key indicator of what a company is worth.